Loading...
Competitive Pressures Will Hinder Urologic Procedures Yet Spur Progress
AnalystLowTarget's Fair Value
US$51.00
35.4% undervalued intrinsic discount04 Sep
US$32.97
1Y
-52.2%7D
0.2%1Y
-52.2%7D
0.2%You can edit this narrative until Aug 6 10:09 PM. Then, changes will post as Updates.